India, Oct. 28 -- India's ambition to move further up the pharmaceutical value chain will increasingly depend not only on manufacturing scale, but on its ability to build deeper capabilities in drug discovery and development.

Against this backdrop, the Medicinal Chemistry, Drug Discovery & Development India 2026 (MCADDI 2026) is bringing together more than 200 professionals, researchers and industry experts for a six-day programme at the University of Hyderabad from October 25 to 30, 2026.

Organised by the Federation of Asian Biotech Associations (FABA) in collaboration with the University of Hyderabad, Biocon Academy, Aragen Academy and Science Gurus, the programme brings together an international faculty and senior industry practition...